News

New imaging promises improved breast cancer utility


 

EXPERT ANALYSIS FROM IMPAKT 2013 BREAST CANCER CONFERENCE

The conference was sponsored by the European Society for Medical Oncology.

Dr. Pinker-Domenig and Dr. Cook had no disclosures. Dr. de Vries said that she has received grant support from Genentech and Novartis.

mzoler@frontlinemedcom.com

On Twitter @mitchelzoler

Pages

Recommended Reading

Ki-67 shows proven clinical utility as a predictive biomarker for breast cancer
Breast Cancer ICYMI
Pulsed-dye laser erased evidence of breast radiation
Breast Cancer ICYMI
Supreme Court ponders patenting of human genes
Breast Cancer ICYMI
Study suggests statin use decreases breast cancer mortality
Breast Cancer ICYMI
Smaller margins too close for comfort in breast cancer
Breast Cancer ICYMI
Online cancer community colaunched by ex-Google executive
Breast Cancer ICYMI
Genetic tests gauge breast-cancer recurrence risk
Breast Cancer ICYMI
Cancer-cell reprogramming poses new treatment challenge
Breast Cancer ICYMI
Intratumor heterogeneity drives need for multiple biopsies
Breast Cancer ICYMI
How I screen patients at increased risk for breast cancer
Breast Cancer ICYMI